The sample only included 308 melanoma cases with the great majority of tests carried out for breast cancer (n=6313), which had a negative correlation with POT1 (OR=0.71, 95% CI 0.53 to 0.945; p=0.019). This evidence concerns the gene POT1 and breast carcinoma.